![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 30, 2014 2:14:20 PM
One of Oncosec's issues is that there main site, the Fred Hutchinson Cancer, has a competing MCC trial at it's site. Dr. Shailender Bhatia is the PI at the site and the main PI for the study. Therefore, we have a very rare disease and he is recruiting patients for two studies.
MCC trial sites for Oncosec;
United States, California
University of California San Francisco Medical Center Recruiting
San Francisco, California, United States, 94143
Contact: Rebecca Bolthouse 415-514-6957 BolthouseR@cc.ucsf.edu
Contact: Siegrid Yu 415-353-7839
Principal Investigator: Siegrid Yu
United States, Washington
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Recruiting
Seattle, Washington, United States, 98109
Contact: Nichole Real 206-288-7476 nreal@seattlecca.org
Contact: Shailender Bhatia 206-288-6765
Principal Investigator: Shailender Bhatia
Sponsors and Collaborators
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM